Co-Diagnostics, Inc. - 8-K Filing
Co-Diagnostics announces 1-for-25 reverse stock split effective November 24, 2026, to maintain Nasdaq compliance. (Items: 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, 3.03 of this Current Report on Form 8-K is incorporated herein by reference, 7.01 Regulation FD, 9.01 Financial Statements and Exhibits)